📈💡 New and interesting player on the pharmaceutical market! 💊🔍
One of the most discussed topics in the pharmaceutical market is the treatment of obesity and diabetes. Only two companies are behind many successful drugs such asOzempic, Rybelsus and Saxenda: Novo Nordisk $NVO and Eli Lilly $LLY. These companies have had significant success in the treatment of diabetes and... Read more
Novo Nordisk A/S is a Danish company that recently introduced a cure for obesity. Shares of $NVO are up more than 20% in the past month and more than 40% this year. For me, the company is going in a good direction and the business is also great, as obesity is really affecting a lot of people at the moment and if the development of this drug goes as well in the future as it has... Read more
The company is doing very well indeed. It's healthy and making solid amounts of money. The chart is logically consistent with that. But now I think it's way up and even though there's no major tooth on the chart, I'm not going to go for it.
Novo Nordisk $NVO closed the day yesterday with a larger market capitalisation than LVMH, making it Europe's largest public company. Novo's share price rose 1.9 percent to $189.3, giving the company a market capitalization of $423 billion.
Have a nice Sunday, what are your views on Novo Nordisk $NVO farm ? Thursday's results were very good and the company is obviously doing very well right now :)
For me, it's $PFEa $LLY.